Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...

A breakthrough AI model analyzes diverse data to reveal faster Alzheimer’s progression in Black females, offering a powerful tool for early detection and personalized care. Study: Prediction and ...

New protective pathway: Scientists found that enhancing nicotine-responsive receptors without nicotine preserved dopamine-producing neurons in female Parkinson’s models. Sex-specific effects: The ...

Knowing who may progress along the disease pathway is critical for early diagnosis and intervention, improved treatment and better disease management, according to a team that has developed a new ...

With a new model of the brain region essential to memory formation, from cells to whole-brain networks, the team hopes to identify critical changes in the progression of Alzheimer's disease that could ...

Researchers also successfully tested the model using data from 1.9 million patients in the Danish National Patient Registry. This approach is one of the most comprehensive demonstrations to date of ...

In this Innovation Spotlight, Gene Mack, the chief executive officer of Gain Therapeutics, discusses the company’s Magellan™ platform, which uss machine learning and structural modeling to identify ...

Multiple sclerosis (MS) has long been regarded as a disease with different subtypes such as “relapsing” or “progressive.” An international study, published on August 20, 2025, in Nature Medicine under ...

The risk for progression of rheumatoid arthritis–associated interstitial lung disease (RA-ILD) was higher in patients with a usual interstitial pneumonia (UIP) pattern, an ILD extent of > 10%, and a ...